NEVVI Medicare utilization intelligence

← back

Provider profile

KINSELLA, VIRGINIA MD

Medical Oncology · NPI 1841289667 · PLANO, TX

1
Groups
47
Codes · 2024
40,262
Disclosed services

KINSELLA, VIRGINIA is a Medical Oncology in PLANO, TX, a member of 1 medical group, who billed 47 distinct codes to Medicare Part B in 2024.

Groups: TEXAS ONCOLOGY PA (DALLAS, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider analytics (2024)

KINSELLA, VIRGINIA billed 44,197 disclosed services in CY2023 and 40,262 in CY2024.

This provider's disclosed Medicare payments across all codes were $premium in CY2024.

The full figure is part of the market analytics platform — built, not launched yet. Notify me at launch →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1756 Injection, iron sucrose, 1 mg premiumpremium premiumpremium
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml premiumpremium premiumpremium
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) premiumpremium premiumpremium
J9271 Injection, pembrolizumab, 1 mg premiumpremium premiumpremium
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg premiumpremium premiumpremium
J0897 Injection, denosumab, 1 mg premiumpremium premiumpremium
J1100 Injection, dexamethasone sodium phosphate, 1 mg premiumpremium premiumpremium
J1626 Injection, granisetron hydrochloride, 100 mcg premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
36415 Insertion of needle into vein for collection of blood sample premiumpremium premiumpremium
80053 Blood test, comprehensive group of blood chemicals premiumpremium premiumpremium
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count premiumpremium premiumpremium
96375 Injection of additional new drug or substance into vein premiumpremium premiumpremium
J2469 Injection, palonosetron hcl, 25 mcg premiumpremium premiumpremium
82728 Ferritin (blood protein) level premiumpremium premiumpremium
83540 Iron level premiumpremium premiumpremium
83550 Iron binding capacity premiumpremium premiumpremium
96413 Administration of chemotherapy into vein, 1 hour or less premiumpremium premiumpremium
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less premiumpremium premiumpremium
96372 Injection of drug or substance under skin or into muscle premiumpremium premiumpremium
83615 Lactate dehydrogenase (enzyme) level premiumpremium premiumpremium
J3489 Injection, zoledronic acid, 1 mg premiumpremium premiumpremium
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour premiumpremium premiumpremium
J1200 Injection, diphenhydramine hcl, up to 50 mg premiumpremium premiumpremium
J7030 Infusion, normal saline solution , 1000 cc premiumpremium premiumpremium
85007 Microscopic examination for white blood cells with manual cell count premiumpremium premiumpremium
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test premiumpremium premiumpremium
J3490 Unclassified drugs premiumpremium premiumpremium
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less premiumpremium premiumpremium
96415 Administration of chemotherapy into vein, each additional hour premiumpremium premiumpremium
96417 Administration of additional new drug or substance into vein, 1 hour or less premiumpremium premiumpremium
71260 Ct scan of chest with contrast premiumpremium premiumpremium
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle premiumpremium premiumpremium
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 premiumpremium premiumpremium
74177 Ct scan of abdomen and pelvis with contrast premiumpremium premiumpremium
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's premiumpremium premiumpremium
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle premiumpremium premiumpremium
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion premiumpremium premiumpremium
85055 Reticulated (young) platelet measurement premiumpremium premiumpremium
99195 Drawing of blood for a medical problem premiumpremium premiumpremium
96361 Infusion into a vein for hydration, each additional hour premiumpremium premiumpremium
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries premiumpremium premiumpremium
78815 Nuclear medicine study from skull base to mid-thigh with ct scan premiumpremium premiumpremium
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg premiumpremium premiumpremium
96374 Injection of drug or substance into vein premiumpremium premiumpremium
71250 Ct scan of chest without contrast premiumpremium premiumpremium
G6012 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.